Apricus Biosciences, Inc. (NASDAQ:APRI)
Apricus Biosciences, Inc. (NASDAQ:APRI) represented a move of 0 percent or $0 per share and closed its previous day trading session at $0.31. 0 Shares were traded in the last trading session with an Average Volume of 815.3 Million Shares. The stock currently has a Market Capitalization of 8.89 Million.
Apricus Bio operates in the pharmaceutical industry and focuses on research and development in the area of drug delivery. Its proprietary drug delivery technology is called NexACT (r). Backed by revenue generating CRO business, Bio-Quant, Inc. and its NexMed USA subsidiary, Apricus Bio has leveraged the flexibility of its proven NexACT(r) drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. The Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer. Apricus Bio was formerly known as NexMed, Inc and is headquartered in San Diago, California.
The stock traded between $0.250 and $3.340 over 1-Year time period showing its price to sales ratio of 0. Apricus Biosciences, Inc. (NASDAQ:APRI) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-4.25 and 200-Day Simple Moving Average of $-20.05. Its Price to Free Cash Flow is 0 and Price to Book of 1.82.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Apricus Biosciences, Inc. (NASDAQ:APRI) reported its Actual EPS of $-0.1/share. The analysts offering Earnings Estimates for the company were believing that Apricus Biosciences, Inc. could bring EPS of $-0.12/share. The difference between Actual EPS and Estimated EPS was 0.02 Percent. Thus showing an Earnings Surprise of 16.7 Percent.
SandRidge Mississippian Trust II (NYSE:SDR)
In the last trading session, SandRidge Mississippian Trust II (NYSE:SDR) added its value by 0% closing at the price of $1.08. The stock currently has market capitalization of 54.21 Million, with average volume of 142.46 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently SandRidge Mississippian Trust II (NYSE:SDR) is showing beta of 0.98. This particular value of beta suggests that SandRidge Mississippian Trust II (NYSE:SDR) has historically moved 98% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for SandRidge Mississippian Trust II (NYSE:SDR) is at $0.23.
The stock currently has RSI of 46.06. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
SandRidge Mississippian Trust II is a Delaware statutory trust formed by SandRidge Energy, Inc. to own certain royalty interests in oil and natural gas wells in the Mississippian formation in northern Oklahoma and southern Kansas. Sandridge Mississippian Trust II is based in Austin, Texas.
SandRidge Mississippian Trust II (NYSE:SDR) topped its 52-week high price of $2.00 on 06/13/18 and 52-Week Low Price of $0.74 on 12/18/17. The Stock currently has P/E (price to earnings ttm) of 4.74 and Weekly volatility of 3.30% and monthly volatility of 5.02% respectively.